Department of Lifestyle-Related Medicine and Endocrinology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:48-53. doi: 10.1111/jgh.12238.
In Japan, the prevalence of obesity in adult men has increased since the 1970s, while that in adult women has not changed. The prevalence of obesity in 5-, 8-, 11-, and 14-year-old boys and girls increased from the late 1980s to late 1990 s and has decreased since 2000, while that in 17-year-old girls increased in 2002, similar to that for boys, but has since decreased. In 2009, 33.3% of adult men and 25.0% of adult women were obese, and 8-10% of children (age, 5-17 years) were obese. The prevalence of visceral obesity in adults was 50.8% of men and 18.0% of women. Obesity, especially visceral obesity, affects insulin resistance and increases metabolic diseases (diabetes mellitus, dyslipidemia, hypertension, cardiovascular disease, and non-alcoholic fatty liver disease [NAFLD]) and various cancers. In Japan, with a body mass index (BMI) of 23-25 as the reference category, the hazard ratio of total mortality is 1.36 for a BMI of 30-40 in men and 1.37 with a BMI of 30-40 in women. The frequency of patients with NAFLD has gradually increased in proportion to the increase in the population with obesity. From recent studies in Japan, the number of NAFLD patients is estimated to be 10 million, and around 2 million are considered to have non-alcoholic steatohepatitis. Dietary and behavioral modification is effective for body weight loss and for improvement of obesity-related gastrointestinal liver diseases. If necessary, bariatric surgery is useful for obesity treatment.
在日本,成年男性的肥胖患病率自 20 世纪 70 年代以来有所增加,而成年女性的肥胖患病率则没有变化。5、8、11 和 14 岁男孩和女孩的肥胖患病率从 20 世纪 80 年代末到 90 年代末有所增加,自 2000 年以来有所下降,而 17 岁女孩的肥胖患病率在 2002 年与男孩相似,但此后有所下降。2009 年,33.3%的成年男性和 25.0%的成年女性肥胖,8-10%的儿童(年龄 5-17 岁)肥胖。成年人内脏肥胖的患病率为男性 50.8%,女性 18.0%。肥胖症,特别是内脏肥胖症,会影响胰岛素抵抗,增加代谢性疾病(糖尿病、血脂异常、高血压、心血管疾病和非酒精性脂肪性肝病[NAFLD])和各种癌症的发病风险。在日本,以 BMI 为 23-25 作为参考类别,男性 BMI 为 30-40 时的总死亡率风险比为 1.36,女性 BMI 为 30-40 时的总死亡率风险比为 1.37。随着肥胖人群的增加,NAFLD 患者的比例逐渐增加。从日本最近的研究来看,估计有 1000 万 NAFLD 患者,约有 200 万人被认为患有非酒精性脂肪性肝炎。饮食和行为改变对减轻体重和改善与肥胖相关的胃肠道肝脏疾病有效。如果需要,减肥手术对肥胖症的治疗有用。